Ken Griffin's position in Nuvation Bio is currently worth $8.01 Million. That's 0.01% of their equity portfolio (1234th largest holding). The investor owns 1.17% of the outstanding Nuvation Bio stock. The first Nuvation Bio trade was made in Q1 2021. Since then Ken Griffin bought shares four more times and sold shares on seven occasions. The investor's estimated purchase price is $30.8 Million, resulting in a loss of 74%.